Related Experiment Videos
[Cerebral MRT in x chromosome linked adrenoleukodystrophy]
1Funktionsbereich Kernspintomographie, Universitätskliniken des Saarlandes, Homburg/Saar.
Bildgebung = Imaging
|January 1, 1991
Summary
Adrenoleukodystrophy (ALD) is a rare lipid storage disease causing white matter demyelination. Magnetic Resonance Tomography (MRT) can reveal characteristic brain changes, aiding early diagnosis before adrenal insufficiency symptoms appear.
Area of Science:
- Neurology
- Radiology
- Genetics
Background:
- Adrenoleukodystrophy (ALD) is a rare genetic lipid storage disorder.
- It is characterized by progressive demyelination of the white matter in the central nervous system.
- ALD affects the adrenal glands and the long tracts of the spinal cord.
Observation:
- Magnetic Resonance Tomography (MRT) demonstrates characteristic leukoencephalopathy.
- This brain involvement begins symmetrically in the occipital lobes.
- Further affected areas include the splenium of the corpus callosum, dentate nucleus, and descending tracts.
Findings:
- Neurologic symptoms may manifest before adrenal insufficiency.
- MRT findings are crucial for suspecting ALD diagnosis.
- Biochemical tests are the standard for confirming ALD.
Implications:
- Early detection of ALD through MRT is vital for timely intervention.
- MRT can guide diagnosis when clinical presentation is ambiguous.
- Understanding imaging patterns aids in differentiating ALD from other demyelinating diseases.